Esparza ML, Sasaki S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study.
Am J Epidemiol. 1995;142:733 - 737.
Lauer K. The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study.
J Clin Epidemiol. 1994;47:43 - 48.
Alter M, Yamoor M, Harshe M. Multiple sclerosis and nutrition.
Arch Neurol.
1974;31:267 - 272.
Esparza ML, Sasaki S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study.
Am J Epidemiol. 1995;142:733 - 737.
Swank RL. Multiple sclerosis: twenty years on low fat diet.
Arch Neurol. 1970;23:460 - 474.
Swank RL, Dugan BB. Effect of low saturated fat diet in early and late cases of multiple sclerosis.
Lancet.1990;336:37 - 39.
Millar JH, Zilkha KJ, Langman MJ, et al. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis.
Br Med J. 1973;1:765 - 768.
Bates D, Fawcett PR, Shaw DA, et al. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.
Br Med J. 1978;2:1390 - 1391.
Paty DW, Cousin HK, Read S, et al. Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit.
Acta Neurol Scand. 1978;58:53 - 58.
Millar JH, Zilkha KJ, Langman MJ, et al. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis.
Br Med J. 1973;1:765 - 768.
Bates D, Fawcett PR, Shaw DA, et al. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.
Br Med J. 1978;2:1390 - 1391.
Paty DW, Cousin HK, Read S, et al. Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit.
Acta Neurol Scand. 1978;58:53 - 58.
Field EJ, Joyce G. Multiple sclerosis: effect of gamma linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids.
Eur Neurol. 1983;22:78 - 83.
Dworkin RH. Linoleic acid and multiple sclerosis [letter].
Lancet. 1981;1:1153 - 1154.
Dworkin RH, Bates D, Millar JH, et al. Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials.
Neurology. 1984;34:1441 - 1445.
Nightingale S, Woo E, Smith AD, et al. Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis.
Acta Neurol Scand. 1990;82:43 - 50.
Cunnane SC, Ho SY, Dore-Duffy P, et al. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis.
Am J Clin Nutr. 1989;50:801 - 806.
Gallai V, Sarchielli P, Trequattrini A, et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids.
J Neuroimmunol. 1995;56:143 - 153.
Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.
Med Hypotheses. 1986;21:193 - 200.
Bates, D. Dietary lipids and multiple sclerosis.
Ups J Med Sci Suppl. 1990;48:173 - 187.
Horrobin DF. Multiple sclerosis: the rational basis for treatment with colchicine and evening primrose oil.
Med Hypotheses. 1979;5:365 - 378.
Field EJ, Joyce G. Effect of prolonged ingestion of gamma-linolenate by MS patients.
Eur Neurol. 1978;17:67 - 76.
Bates, D. Dietary lipids and multiple sclerosis.
Ups J Med Sci Suppl. 1990;48:173 - 187.
Horrobin DF. Multiple sclerosis: the rational basis for treatment with colchicine and evening primrose oil.
Med Hypotheses. 1979;5:365 - 378.
Lee A, Patterson V. A double-blind study of L-threonine in patients with spinal spasticity.
Acta Neurol Scand. 1993;88:334 - 338.
Hauser SL, Doolittle TH, Lopez-Bresnahan M, et al. An antispasticity effect of threonine in multiple sclerosis.
Arch Neurol. 1992;49:923 - 926.
Hauser SL, Doolittle TH, Lopez-Bresnahan M, et al. An antispasticity effect of threonine in multiple sclerosis.
Arch Neurol. 1992;49:923 - 926.
Lee A, Patterson V. A double-blind study of L-threonine in patients with spinal spasticity.
Acta Neurol Scand. 1993;88:334 - 338.
Baig SM, Qureshi GA, Minami M. The interrelation between the deficiency of vitamin B12 and neurotoxicity of homocysteine with nitrite in some of neurologic disorders.
Biogenic Amines. 1998;14:1 - 14.
Reynolds EH. Multiple sclerosis and vitamin B12 metabolism.
J Neuroimmunol. 1992;40:225 - 230.
Goodkin DE, Jacobsen DW, Galvez N, et al. Serum cobalamin deficiency is uncommon in multiple sclerosis.
Arch Neurol. 1994;51:1110 - 1114.
Reynolds EH. Multiple sclerosis and vitamin B12 metabolism.
J Neuroimmunol. 1992;40:225 - 230.
Kira J, Tobimatsu S, Goto I. Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis.
Intern Med. 1994;33:82 - 86.
Simpson CA, Newell DJ, Miller H. The treatment of multiple sclerosis with massive doses of hydroxocobalamin.
Neurology. 1965;15:599 - 603.
Goldberg P. Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part I: Sunlight, dietary factors and epidemiology.
Int J Environ Studies.
1974;6:19-27.
Hayes CE, Cantorna MT, DeLuca HF. Vitamin D and multiple sclerosis.
Proc Soc Exp Biol Med. 1997;216:21 - 27.
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety.
Am J Clin Nutr. 1999;69:842 - 856.
Schwartz GG. Multiple sclerosis and prostate cancer: what do their similar geographies suggest?
Neuroepidemiology. 1992;11:244 - 254.
Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D.
Med Hypotheses. 1986;21:193 - 200.
Winter A. New treatment for multiple sclerosis.
Neurol Orthop J Med Surg. 1984;5:39 - 43.
Winter A. New treatment for multiple sclerosis.
Neurol Orthop J Med Surg. 1984;5:39 - 43.
Gibson RG, Gibson SL. Neural therapy in the treatment of multiple sclerosis.
J Altern Complement Med. 1999;5:543 - 552.
Brochet B, Guinot P, Orgogozo JM, et al. Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis.
J Neurol Neurosurg Psychiatry. 1995;58:360 - 362.
Richards TL, Lappin MS, Acosta-Urquidi J, et al. Double-blind study of pulsing magnetic field effects on multiple sclerosis.
J Altern Complement Med. 1997;3:21 - 29.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.